123 related articles for article (PubMed ID: 35223528)
21. ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.
Zhou Y; Zhou Y; Wang K; Li T; Zhang M; Yang Y; Wang R; Hu R
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783584
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.
Zhou L; Jia S; Ding G; Zhang M; Yu W; Wu Z; Cao L
J Cancer; 2019; 10(21):5031-5040. PubMed ID: 31602254
[TBL] [Abstract][Full Text] [Related]
23. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance.
Wang X; Cheng K; Zhang G; Jia Z; Yu Y; Guo J; Hua Y; Guo F; Li X; Zou W; Sun H; Dong J; Yang Z
Front Oncol; 2020; 10():960. PubMed ID: 32760666
[TBL] [Abstract][Full Text] [Related]
25. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer.
Amrutkar M; Gladhaug IP
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546284
[TBL] [Abstract][Full Text] [Related]
26. miR-3940-5p/miR-8069 ratio in urine exosomes is a novel diagnostic biomarker for pancreatic ductal adenocarcinoma.
Yoshizawa N; Sugimoto K; Tameda M; Inagaki Y; Ikejiri M; Inoue H; Usui M; Ito M; Takei Y
Oncol Lett; 2020 Apr; 19(4):2677-2684. PubMed ID: 32218818
[TBL] [Abstract][Full Text] [Related]
27. The Proteome of Pancreatic Cancer-Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways.
Han S; Huo Z; Nguyen K; Zhu F; Underwood PW; Basso KBG; George TJ; Hughes SJ
Proteomics; 2019 Jul; 19(13):e1800394. PubMed ID: 31070281
[TBL] [Abstract][Full Text] [Related]
28. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
Wang J; Yeung BZ; Cui M; Peer CJ; Lu Z; Figg WD; Guillaume Wientjes M; Woo S; Au JL
J Control Release; 2017 Dec; 268():147-158. PubMed ID: 29054369
[TBL] [Abstract][Full Text] [Related]
29. Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.
Gao Y; Chen MK; Chu YY; Yang L; Yu D; Liu Y; Hung MC
Am J Cancer Res; 2021; 11(1):236-250. PubMed ID: 33520371
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
Huang B; Wang J; Chen Q; Qu C; Zhang J; Chen E; Zhang Y; Wang Y; Ni L; Liang T
Am J Transl Res; 2019; 11(1):473-485. PubMed ID: 30788003
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma.
Shao F; Huang M; Meng F; Huang Q
Front Pharmacol; 2018; 9():584. PubMed ID: 29922161
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling.
Wang H; Min J; Xu C; Liu Y; Yu Z; Gong A; Xu M
J Cancer; 2023; 14(6):1075-1087. PubMed ID: 37151398
[TBL] [Abstract][Full Text] [Related]
33. Proteomics-Based Characterization of the Effects of MMP14 on the Protein Content of Exosomes from Corneal Fibroblasts.
Han KY; Chang JH; Azar DT
Protein Pept Lett; 2020; 27(10):979-988. PubMed ID: 32268857
[TBL] [Abstract][Full Text] [Related]
34. N1-guanyl-1, 7-diaminoheptane enhances the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine via the inhibition of eukaryotic translation initiation factor 5A2.
Yao M; Hong Y; Liu Y; Chen W; Wang W
Exp Ther Med; 2017 Sep; 14(3):2101-2107. PubMed ID: 28962130
[TBL] [Abstract][Full Text] [Related]
35. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
Massoumi RL; Hines OJ; Eibl G; King JC
Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
[TBL] [Abstract][Full Text] [Related]
36. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
[TBL] [Abstract][Full Text] [Related]
37. Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence.
Molejon MI; Tellechea JI; Moutardier V; Gasmi M; Ouaissi M; Turrini O; Delpero JR; Dusetti N; Iovanna J
Oncoscience; 2015; 2(6):572-5. PubMed ID: 26244163
[TBL] [Abstract][Full Text] [Related]
38. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X
Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702
[TBL] [Abstract][Full Text] [Related]
39. MMP14-Containing Exosomes Cleave VEGFR1 and Promote VEGFA-Induced Migration and Proliferation of Vascular Endothelial Cells.
Han KY; Chang JH; Azar DT
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2321-2329. PubMed ID: 31117124
[TBL] [Abstract][Full Text] [Related]
40. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance.
Di Donato M; Medici N; Migliaccio A; Castoria G; Giovannelli P
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
